Cutting edge: Vα14-jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice

Journal of Immunology

Volumn 168, Issue 12, 2002, Pages 6007-6011

  Mars, Lennart T ^a   Laloux, Véronique ^a   Goude, Karine ^a   Desbois, Sabine ^a   Saoudi, Abdelhadi ^a   Van Kaer, Luc ^a   Lassmann, Hans ^a   Herbelin, André ^a   Lehuen, Agnès ^a   Liblau, Roland S ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE;

EID: 0037097505     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.12.6007     Document Type: Article

References (28)

1. The role of different subsets of T regulatory cells in controlling autoimmunity
2. Autoreactivity by design: Innate B and T lymphocytes
3. + NK T cells associated with disease development in autoimmune-prone mice
4. +-like thymocytes in the NOD mouse
5. Extreme Th1 bias of invariant Vα24JαQ T cells in type I diabetes
6. Selective reduction and recovery of invariant Vα24JαQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus
7. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10
8. A defect in interleukin 12-induced activation and interferon γ secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus
9. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes
10. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type I diabetes
11. Differential expression of NK T cell Vα24JαQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy
12. - T cells that promptly produce interleukin 4
13. + T cells
14. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα14 NK T cells
15. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells
16. Th1 to Th2 cytokine shifts in nonobese diabetic mice: Sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation
17. CD1dl mutant mice are deficient in natural T cells that promptly produce IL-4
18. Comparing proportions from independent samples
19. Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse
20. NK T cell-induced protection against diabetes in Vα14-Jα281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen
21. Cutting edge: Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
22. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance
23. Activation-induced expression of CD1d antigen on mature T cells
24. + thymocyte population associated with intact Fas antigen expression on the target
25. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells
26. CD1 expression is differentially regulated by microglia, macrophages and T cells in the central nervous system upon inflammation and demyelination
27. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis
28. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis